| OTC Markets: GTOP
Genitope Corp. is a biotechnology company, which is focused on the research and development of novel immunotherapies for the treatment of cancer. Its Immunotherapy products are designed to utilize the immune system to combat diseases such as cancer. The company's product, MyVax a Personalized Immunotherapy is in the pivotal Phase 3 trial for the treatment of follicular non-Hodgkin's lymphoma. The firm intends to manufacture commercial quantities of MyVax Personalized Immunotherapy. The company was founded on August 15, 1996 and is headquartered in Fremont, CA.